BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy
Titel:
BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPTP301S mouse model of tauopathy
Auteur:
Perez-Garcia, Georgina Bicak, Mesude Haure-Mirande, Jean-Vianney Perez, Gissel M. Otero-Pagan, Alena Gama Sosa, Miguel A. De Gasperi, Rita Sano, Mary Barlow, Carrolee Gage, Fred H. Readhead, Benjamin Ehrlich, Michelle E. Gandy, Sam Elder, Gregory A.